During a live event, Nathan M. Denlinger, DO, MS, discussed the PILOT and ALYCANTE trials of CAR T-cell therapy in transplant-ineligible B-cell lymphoma.

A new study published in Nature Cancer reveals that age-related metabolic decline impairs the efficacy of CAR-T cell therapy.

Personalized medicine is already a reality in clinical practice, and CAR-T cell therapy is one of its most promising tools.

Memorial Sloan Kettering Cancer Center investigators report that T cell interferon-γ (IFNγ) orchestrates a ...

In biology classes from high school through university, I learned that mitochondria are little objects that reside within ...

It was announced that the live-action movie adaptation of Akane Shimizu’s Cells at Work! manga series is coming to Netflix! The movie is slated to premiere on the streaming service on June 13! An ...

Cytotoxic T lymphocytes and natural killer cells destroy target cells using a mechanically active cytolytic immune synapse. This Review examines the various ways in which mechanical forces ...

SOUTH SAN FRANCISCO, Calif., May 08, 2025 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (Nasdaq: CRVS), a clinical-stage biopharmaceutical company, today provided a business update and reported ...

First Steps director Matt Shakman has confirmed that the movie will feature more than one H.E.R.B.I.E., and along with ...

Newly discovered oncology drugs called “DNA-encoded tri-specific T-cell engagers,” or “DTriTEs,” engage the immune system ...

The research indicates that reprogrammed T helper cells adopt characteristics of a new T helper cell type while preserving some of their original traits, making them “super powerful and potent ...